Upload
independent
View
0
Download
0
Embed Size (px)
Citation preview
Captopril and its dimer captoprildisulfide: comparative structural andconformational studies
Joanna Bojarska,a Waldemar Maniukiewicz,a* Andrzej
Fruzinski,a Lesław Sierona and Milan Remkob
aInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University
of Technology, Z.eromskiego 116, 90-924 Łodz, Poland, and bDepartment of
Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University Bratislava,
Odbojarov 10, SK-832 32 Bratislava, Slovakia
Correspondence e-mail: [email protected]
Received 12 January 2015
Accepted 6 February 2015
The crystal structures of captopril {systematic name: (2S)-1-
[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic
acid}, C9H15NO3S, (1), and its dimer disulfide metabolite, 1,10-
{disulfanediylbis[(2S)-2-methyl-1-oxopropane-3,1-diyl]}bis-l-
proline, C18H28N2O6S2, (2), were determined by single-crystal
X-ray diffraction analysis. Compound (1) crystallizes in the
orthorhombic space group P212121, while compound (2)
crystallizes in the monoclinic space group P21, both with one
molecule per asymmetric unit. The molecular geometries of
(1) and (2) are quite similar, but certain differences appear in
the conformations of the five-membered proline rings and the
side chains containing the sulfhydryl group. The proline ring
adopts an envelope conformation in (1), while in (2) it exists in
envelope and slightly deformed half-chair conformations. The
conformation adopted by the side chain is extended in (1) and
folded in (2). A minimum-energy conformational search using
Monte Carlo methods in the aqueous phase reveals that the
optimized conformations of the title compounds differ from
those determined crystallographically, which depend on their
immediate environment. Intermolecular O—H� � �O and
relatively weak C—H� � �O interactions seem to be effective
in both structures and, together with S—H� � �O and C—H� � �S
contacts, they create three-dimensional networks.
Keywords: captopril; captopril disulfide; crystal structure;conformational search; hydrogen-bond motifs; angiotensin-converting enzyme (ACE) inhibitors; theoretical calculations.
1. Introduction
Captopril, (1) (see Scheme), is a well known drug and a
member of a class of drugs called angiotensin-converting
enzyme (ACE) inhibitors. It was developed in 1975 (Ondetti et
al., 1977). ACE inhibitors are used mainly for treating high
blood pressure, since they effectively block the conversion of
angiotensin I (decapeptide) to angiotensin II (vasoconstricting
octapeptide). They also possess some additional medical
properties, such as vasculoprotective and antithrombotic
activities, that can play a favourable role in terms of cardio-
vascular morbidity. It is well known that cardiovascular
diseases are one of the world’s largest killers (Kantevari et al.,
2011). Captopril (trade name Capoten) has an established
position in the medical treatment of hypertension and
congestive heart failure. It is the preferred drug of and is
extensively prescribed to patients who are chronically ill and
require long-term treatment, due to its therapeutic benefits
and because of its effectiveness, low price and low toxicity. It is
noteworthy that it has also been investigated for use in the
treatment of cancer (Attoub et al., 2008).
Captopril is oxidized spontaneously after dissolution in
water to form captopril disulfide, (2), its major metabolite, in
which the disulfide bond links two units of captopril
(Sweetman, 2009) (see Scheme).
Despite the fact that ACE inhibitors have been known for a
long time, their three-dimensional structures have not been
precisely characterized, thus leaving some uncertainties.
Recently, we have reported three-dimensional data for the
perindopril derivatives, including perindopril tert-butylamine
salt [Cambridge Structural Database (CSD; Version 5.35, last
update May 2014; Groom & Allen, 2014) refcodes IVEGIA
and IVEGOG; Remko et al., 2011], solvates of perindoprilat,
the active metabolite of perindopril (CSD refcodes FEFKEI
and BECWIR; Bojarska, Maniukiewicz, Sieron, Fruzinski et
al., 2012; Bojarska, Maniukiewicz, Sieron, Kopczacki et al.,
2012), and the DKP–perindopril tetragonal (CSD refcodes
BILNAN01 and BILNAN02; Bojarska et al., 2013a) and
orthorhombic (CSD refcode BILNAN; Bojarska et al., 2013b;
Remko et al., 2013) polymorphs. The present work is a
continuation of our structural studies of ACE inhibitors. The
aim of this paper was to determine the crystal structures of
captopril and its dimer metabolite with high precision and
compare them with the captopril thiol analogue 4-carboxy-3-
(2-mercaptoisobutyryl)thiazole (CSD refcode DIVHEV; In et
al., 1986). Special attention was paid to the relationship
between the crystalline environment of the molecules and the
molecular conformation, in addition to the hydrogen-bond
patterns.
The crystal structure of (1) was determined with poor
quality at ambient temperature almost 20 years ago (Fujinaga
& James, 1980); data were deposited without H-atom positions
research papers
Acta Cryst. (2015). C71 doi:10.1107/S2053229615002582 # 2015 International Union of Crystallography 1 of 5
Acta Crystallographica Section C
Structural Chemistry
ISSN 2053-2296
in the CSD (refcode MCPRPL). Herein, we report the
detailed three-dimensional structure of (1), established with
high precision at low temperature (100 K), including an
analysis of the conformational puckering parameters and the
graph sets of the hydrogen-bond patterns. The crystal struc-
ture of captopril disulfide, (2), is also reported here, for the
first time, to the best of our knowledge.
2. Experimental
Theoretical calculations by means of conformational searches
were performed using the Monte Carlo method (mixed
MCMM/low-mode sampling) as implemented in MacroModel
(Schrodinger, 2014), with an OPLS-2005 (optimized potential
for liquid simulations) force field and the TNCG (truncated
Newton conjugate gradient) method of energy minimization.
The analysis was carried out for an aqueous solution with
continuum solvation treatment (generalized Born/solvent
accessible, GB/SA) (Maestro and MacroModel; Schrodinger,
2014). Crystallographic data for the title compounds were
used as a starting point for the theoretical calculations.
2.1. Crystallization
Captopril and captopril disulfide were obtained commer-
cially (Sigma–Aldrich). Colourless prismatic well-shaped
crystals of (1) and plate-shaped crystals of (2) were grown
from acetone and tetrahydrofuran–water (1:1 v/v) solutions,
respectively, by slow evaporation at room temperature over a
period of several days.
2.2. Refinement
Crystal data, data collection and structure refinement
details are summarized in Table 1. H atoms were located in
difference Fourier maps. In the case of (1), H atoms were
refined freely. In the case of (2), C-bound H atoms were
geometrically optimized and allowed for as riding atoms, with
C—H = 0.98 A for methyl, 0.99 A for methylene and 1.00 A
for methine groups, and with Uiso(H) = 1.5Ueq(C) for methyl H
atoms and 1.2Ueq(C) for methylene and methane H atoms. H
atoms on O atoms were treated with O—H = 0.84 A.
3. Results and discussion
Perspective views of the molecular structures of (1) and (2)
are presented in Figs. 1 and 2, respectively. The overall
conformational preferences of the title compounds can be
divided into two parts: (i) the ring conformation, including the
carboxylic acid group, and (ii) the conformation of the linker,
including the carbonyl and methyl groups. In the present
study, the geometric parameters of the captopril molecules are
rather similar, favouring an envelope conformation for the
proline rings (atoms N1–C5/C8), as confirmed by the ring-
puckering parameters (Cremer & Pople, 1975; Spek, 2009) Q =
0.3693 (19) A and ’ = 248.4 (3)� for (1), and Q = 0.401 (6) A
research papers
2 of 5 Bojarska et al. � C9H15NO3S and C18H28N2O6S2 Acta Cryst. (2015). C71
Table 1Experimental details.
(1) (2)
Crystal dataChemical formula C9H15NO3S C18H28N2O6S2
Mr 217.28 432.54Crystal system, space group Orthorhombic, P212121 Monoclinic, P21
Temperature (K) 100 100a, b, c (A) 6.8001 (1), 8.8015 (2), 17.4805 (3) 6.6678 (4), 11.0680 (6), 14.4219 (8)�, �, � (�) 90, 90, 90 90, 91.925 (2), 90V (A3) 1046.23 (3) 1063.72 (10)Z 4 2Radiation type Cu K� Cu K�� (mm�1) 2.63 2.59Crystal size (mm) 0.45 � 0.25 � 0.15 0.25 � 0.20 � 0.15
Data collectionDiffractometer Bruker SMART APEXII CCD area-detector
diffractometerBruker SMART APEXII CCD area-detector
diffractometerAbsorption correction Multi-scan (SADABS; Sheldrick, 2003) Multi-scan (SADABS; Sheldrick, 2003)Tmin, Tmax 0.572, 0.754 0.622, 0.753No. of measured, independent and observed
[I > 2�(I)] reflections10959, 1946, 1944 11298, 3675, 3626
Rint 0.021 0.019(sin �/�)max (A�1) 0.609 0.603
RefinementR[F 2 > 2�(F 2)], wR(F 2), S 0.020, 0.052, 1.09 0.041, 0.105, 1.04No. of reflections 1946 3675No. of parameters 188 255No. of restraints 0 1H-atom treatment All H-atom parameters refined H-atom parameters constrained�max, �min (e A�3) 0.16, �0.16 0.44, �0.25Absolute structure Flack x parameter determined using 772 quotients
[(I+) � (I�)]/[(I+) + (I�)] (Parsons et al., 2013)Flack x parameter determined using 1578 quotients
[(I+) � (I�)]/[(I+) + (I�)] (Parsons et al., 2013)Absolute structure parameter 0.072 (5) 0.007 (8)
Computer programs: APEX2 (Bruker, 2005), SAINT-Plus (Bruker, 2008), SHELXS97 (Sheldrick, 2008), SHELXL2013 (Sheldrick, 2015) and Mercury (Macrae et al., 2008).
and ’ = 109.9 (7)� for (2). Nevertheless, we observed a subtle
difference for one proline ring in the case of the captopril
dimer (2) (N11–C15/C18), which possesses a slightly deformed
half-chair conformation, having total puckering parameters
Q = 0.385 (5) A and ’ = 96.3 (7)�.
The terminal carboxylic acid group adopts an antiperiplanar
conformation in (1) and a synperiplanar conformation in (2), a
consequence of the differing hydrogen-bonding geometries
involving these groups, as described below. The sulfur-
containing side chain is extended in (1) but folded in (2). An
overlay (on the common amide plane) of the title structures,
including the thiol analogue of captopril (CSD refcode
DIVHEV; In et al., 1986), is presented in Fig. 3. The central
part of (2), i.e. the C1—S1—S11—C11 fragment, adopts a
skewed nonplanar configuration, with a dihedral angle of
�73.5 (2)� and an S1—S11 bond distance of 2.042 (1) A. This
is consistent with stereoelectronic effects and repulsions
between the lone pairs of electrons on the S atoms (Hordvik et
al., 1966).
Captopril and its disulfide metabolite reveal interesting
supramolecular networks created via hydrogen bonds. In the
studied crystals, there are only intermolecular hydrogen
bonds; the orientation of the carboxylic acid groups is such
that it precludes the possibility of an intramolecular hydrogen
bond between atoms O3 and O1, rather an intermolecular
hydrogen bond forms between atom O3 and atom O1 of an
adjacent molecule. The packing motifs of (1) and (2) are
dominated by classical O—H� � �O and nonclassical C—H� � �O
interactions, creating a three-dimensional hydrogen-bonding
network. Both structures have similar geometric parameters
for these hydrogen bonds (D� � �A = 2.59–2.68 A for O—
H� � �O and 3.26–3.41 A for C—H� � �O).
Hydrogen bonds formed by the sulfhydryl group, believed
to have some involvement in the physiological processes of
captopril, are worthy of mention. The –SH group acts as a
donor (S—H� � �O) in the case of captopril but as an acceptor
(C—H� � �S) in the disulfide metabolite. All hydrogen-bond
contacts are listed in Tables 2 and 3.
For (1), the O3—H3O� � �O1ii hydrogen bond links the
molecules into a helical chain extending along the crystal-
lographic b axis (see Tables 2 and 3 for all symmetry codes;
Fig. 4), with a C(7) graph-set motif (Etter et al., 1990; Bern-
stein et al., 1995). For (2), which reveals a richer system of
hydrogen-bond contacts than (1) due to the larger number of
hydrogen-bond donors and acceptors in the structure, the
O3—H3O� � �O1v and O13—H13O� � �O11vi interactions link
the molecules into a sheet that lies perpendicular to [101], with
similar C(7) graph-set motifs. Moreover, in (1), C1—
H1A� � �O3iii and O3—H3O� � �O1ii hydrogen bonds result in
research papers
Acta Cryst. (2015). C71 Bojarska et al. � C9H15NO3S and C18H28N2O6S2 3 of 5
Figure 1The molecular structure of captopril, (1), showing the atom-numberingscheme. Displacement ellipsoids are drawn at the 50% probability level.
Figure 2The molecular structure of the captopril disulfide metabolite, (2), showingthe atom-numbering scheme. Displacement ellipsoids are drawn at the50% probability level.
Figure 3A superimposition, with respect to the amide plane, showing theconformational differences, in the solid state, between (1) (blue), (2)(green) and DIVHEV (magenta) (In et al., 1986). H atoms have beenomitted for clarity.
Table 3Hydrogen-bond geometry (A, �) for (2).
D—H� � �A D—H H� � �A D� � �A D—H� � �A
O3—H3O� � �O1v 0.84 1.85 2.677 (5) 168O13—H13O� � �O11vi 0.84 1.82 2.644 (5) 167C1—H1A� � �S11vii 0.99 2.87 3.707 (4) 143C11—H11A� � �O12viii 0.99 2.44 3.307 (7) 146C13—H13C� � �O12viii 0.98 2.52 3.405 (7) 151C15—H15A� � �O12vii 0.99 2.28 3.255 (7) 170C18—H18� � �S1ix 1.00 2.81 3.709 (4) 149
Symmetry codes: (v) �x; yþ 12;�zþ 1; (vi) �x þ 2; y� 1
2;�z; (vii) x� 1; y; z; (viii)�x þ 2; yþ 1
2;�z; (ix) xþ 1; y; z.
Table 2Hydrogen-bond geometry (A, �) for (1).
D—H� � �A D—H H� � �A D� � �A D—H� � �A
S1—H1S� � �O2i 1.26 (3) 2.40 (3) 3.5165 (12) 146.2 (18)O3—H3O� � �O1ii 0.80 (3) 1.80 (3) 2.5881 (17) 169 (3)C1—H1A� � �O3iii 1.00 (2) 2.53 (2) 3.300 (2) 133.8 (19)C5—H5A� � �O2iv 0.98 (2) 2.58 (2) 3.408 (2) 142.4 (15)
Symmetry codes: (i) x� 1; y; z; (ii) �xþ 1; y þ 12;�zþ 1
2; (iii) �xþ 1; y� 12;�zþ 1
2; (iv)x � 1
2;�yþ 32;�zþ 1.
the formation of a seven-membered ring with an R22(7) motif,
generating a sheet. Within this sheet, an additional 15-
membered ring with an R23(15) motif is formed through S1—
H1S� � �O2i and C5—H5A� � �O2iv interactions. In (2), three-
dimensional C22(28) chains and edge-fused R4
4(42) rings are
formed (Table 3 and Fig. 5). Large C44(56) chains and R6
6(70)
rings are also observed.
Captopril, like other ACE inhibitors, is a conformationally
flexible molecule. In the case of its disulfide, the molecular
flexibility is increased further due to the greater number of
torsional degrees of freedom. A conformational search using
the Monte Carlo method was used to predict the energetically
favourable conformations of the title compounds in an
aqueous environment. The conformational analysis was initi-
ated with the crystallographic geometry of the studied mol-
ecules. A particular analysis taking into account the dihedral
angles, viz. the crystallographic data, was performed.
Comparisons of the torsion angles obtained from the X-ray
data and the Monte Carlo simulations are given in the
archived CIF. Generally, the simulated structures adopt
different conformations to those determined by the crystal-
lographic analysis, suggesting that the conformations of
captopril and its dimer metabolite are very sensitive to their
immediate environment. Not surprisingly, the greatest differ-
ence between the theoretical and experimental structures of
(1) is the orientation of the proline –COOH group, which is
influenced by hydrogen-bonding interactions in the solid state.
The N1—C8—C9—O2 and N1—C8—C9—O3 torsion angles
are the most different. As might be expected, in (2) there is
considerably greater variability among the torsion angles
between the theoretical and crystallographically determined
structures. Inspection of the torsion angles for the calculated
low-energy conformation of (2) compared with the X-ray data
suggests that more than half of them are responsible for
various conformations. Overlays of the solid-state (crystalline)
and simulated molecular geometries of the title compounds
are shown in Fig. 6, illustrating the essential differences
between them. The r.m.s. fits of the calculated conformations
closely match those of the crystallographic conformations
[r.m.s. deviations: 0.0258 A for (1) and 0.0242 A for (2)].
In conclusion, redetermination of the structure of (1) has
revealed important and interesting features, including a
detailed hydrogen-bond analysis, which was impossible in the
earlier report containing only a very brief structural descrip-
tion. Moreover, the captopril disulfide metabolite, (2), has
been successfully resolved for the first time, to the best of our
research papers
4 of 5 Bojarska et al. � C9H15NO3S and C18H28N2O6S2 Acta Cryst. (2015). C71
Figure 4A partial packing diagram for (1). Intermolecular hydrogen bonds areindicated by dashed lines. H atoms not involved in hydrogen bonds havebeen omitted for clarity. [Symmetry codes: (i) x� 1, y, z; (ii)�x + 1, y + 1
2,�z + 1
2; (iii) �x + 1, y � 12, �z + 1
2; (iv) x � 12, �y + 3
2, �z + 1.]
Figure 5The crystal packing of (2). Intermolecular hydrogen bonds are indicatedby dashed lines. H atoms not involved in hydrogen bonds have beenomitted for clarity. [Symmetry codes: (v) �x, y + 1
2, �z + 1; (vi) �x + 2,y � 1
2, �z; (vii) x � 1, y, z; (viii) �x + 2, y + 12, �z; (ix) x + 1, y, z.]
Figure 6An overlay, with respect to the amide plane along the N1—C4—C2 angle,of the crystallographic (turquoise) and theoretical (brown) conforma-tions of captopril, (1) (on the left), and captopril disulfide, (2) (on theright). H atoms have been omitted for simplicity.
knowledge. Comparative analysis revealed some conforma-
tional similarities but also important differences. Additionally,
the conformations of both compounds were studied by the
Monte Carlo method in an aqueous environment. The theo-
retical outcomes of the conformational minimum differ from
those in the crystalline environment, confirming the high
plasticity of the conformations and their dependence on the
environment.
References
Attoub, S., Gaben, A. M., Al-Salam, S., Al Sultan, M. A. H., John, A., Nicholls,M. G., Mester, J. & Petroianu, G. (2008). Ann. N. Y. Acad. Sci. 1138, 65–72.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem.Int. Ed. Engl. 34, 1555–1573.
Bojarska, J., Maniukiewicz, W., Sieron, L., Fruzinski, A., Kopczacki, P.,Walczynski, K. & Remko, M. (2012). Acta Cryst. C68, o341–o343.
Bojarska, J., Maniukiewicz, W., Sieron, L., Kopczacki, P., Walczynski, K. &Remko, M. (2012). Acta Cryst. C68, o443–o446.
Bojarska, J., Maniukiewicz, W., Sieron, L. & Remko, M. (2013a). J. Chil. Chem.Soc. 58, 1415–1417.
Bojarska, J., Maniukiewicz, W., Sieron, L. & Remko, M. (2013b). Acta Cryst.C69, 630–633.
Bruker (2005). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.Bruker (2008). SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354–1358.Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256–
262.Fujinaga, M. & James, M. N. G. (1980). Acta Cryst. B36, 3196–3199.Groom, C. R. & Allen, F. H. (2014). Angew. Chem. Int. Ed. 53, 662–671.Hordvik, A., Grjotheim, K., Krohn, C., Motzfeldt, K., Williams, D. H.,
Bunnenberg, E., Djerassi, C. & Records, R. (1966). Acta Chem. Scand. 20,1885–1891.
In, Y., Shibata, M., Doi, M., Ishida, T., Inoue, M., Sasaki, Y. & Morimoto, S.(1986). Chem. Commun. pp. 473–474.
Kantevari, S., Addla, D., Bagul, P. K., Sridhar, B. & Banerjee, S. K. (2011).Bioorg. Med. Chem. 19, 4772–4781.
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P.,Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood,P. A. (2008). J. Appl. Cryst. 41, 466–470.
Ondetti, M., Rubin, B. & Cushman, W. (1977). Science, 196, 441–444.Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259.Remko, M., Bojarska, J., Jezko, P., Maniukiewicz, W. & Olczak, A. (2013).
J. Mol. Struct. 1036, 292–297.Remko, M., Bojarska, J., Jezko, P., Sieron, L., Olczak, A. & Maniukiewicz, W.
(2011). J. Mol. Struct. 997, 103–109.Schrodinger (2014). Maestro and MacroModel. Schrodinger LLC, New York,
USA.Sheldrick, G. M. (2003). SADABS. University of Gottingen, Germany.Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122.Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.Spek, A. L. (2009). Acta Cryst. D65, 148–155.Sweetman, S. C. (2009). Martindale: The Complete Drug Reference, 36th ed.,
pp. 1239–1240. London, Chicago: Pharmaceutical Press.
research papers
Acta Cryst. (2015). C71 Bojarska et al. � C9H15NO3S and C18H28N2O6S2 5 of 5
supporting information
sup-1Acta Cryst. (2015). C71
supporting information
Acta Cryst. (2015). C71 [doi:10.1107/S2053229615002582]
Captopril and its dimer captopril disulfide: comparative structural and
conformational studies
Joanna Bojarska, Waldemar Maniukiewicz, Andrzej Fruziński, Lesław Sieroń and Milan Remko
Computing details
For both compounds, data collection: APEX2 (Bruker, 2005); cell refinement: SAINT-Plus (Bruker, 2008); data reduction:
SAINT-Plus (Bruker, 2008); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL2013 (Sheldrick, 2015); molecular graphics: Mercury (Macrae et al., 2008); software used to prepare
material for publication: SHELXL2013 (Sheldrick, 2015).
(1) (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Crystal data
C9H15NO3SMr = 217.28Orthorhombic, P212121
a = 6.8001 (1) Åb = 8.8015 (2) Åc = 17.4805 (3) ÅV = 1046.23 (3) Å3
Z = 4F(000) = 464
Dx = 1.379 Mg m−3
Cu Kα radiation, λ = 1.54178 ÅCell parameters from 9925 reflectionsθ = 5.0–72.4°µ = 2.63 mm−1
T = 100 KPlate, colourless0.45 × 0.25 × 0.15 mm
Data collection
Bruker SMART APEXII CCD area-detector diffractometer
Radiation source: 30W microsource with MonoCap capillary
Graphite monochromatorω scansAbsorption correction: multi-scan
(SADABS; Sheldrick, 2003)Tmin = 0.572, Tmax = 0.754
10959 measured reflections1946 independent reflections1944 reflections with I > 2σ(I)Rint = 0.021θmax = 70.0°, θmin = 5.1°h = −8→8k = −10→10l = −18→21
Refinement
Refinement on F2
Least-squares matrix: fullR[F2 > 2σ(F2)] = 0.020wR(F2) = 0.052S = 1.091946 reflections188 parameters0 restraintsHydrogen site location: difference Fourier map
All H-atom parameters refinedw = 1/[σ2(Fo
2) + (0.0256P)2 + 0.237P] where P = (Fo
2 + 2Fc2)/3
(Δ/σ)max < 0.001Δρmax = 0.16 e Å−3
Δρmin = −0.16 e Å−3
Extinction correction: SHELXL (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.0066 (7)
supporting information
sup-2Acta Cryst. (2015). C71
Absolute structure: Flack x parameter determined using 772 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Absolute structure parameter: 0.072 (5)
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O3 0.7441 (2) 0.86441 (14) 0.29735 (7) 0.0227 (3)H3O 0.711 (4) 0.923 (3) 0.2652 (15) 0.038 (7)*O2 0.63409 (19) 0.74724 (13) 0.40010 (7) 0.0217 (3)O1 0.33242 (19) 0.58147 (13) 0.29799 (7) 0.0194 (3)N1 0.2439 (2) 0.79069 (14) 0.36212 (7) 0.0127 (3)C9 0.6006 (2) 0.82286 (18) 0.34374 (10) 0.0158 (3)C8 0.3957 (2) 0.88008 (18) 0.32299 (9) 0.0133 (3)H8 0.379 (3) 0.873 (2) 0.2698 (10) 0.006 (4)*C7 0.3636 (3) 1.04376 (19) 0.35246 (11) 0.0191 (4)H7B 0.457 (4) 1.067 (3) 0.3961 (13) 0.027 (6)*H7A 0.384 (3) 1.119 (2) 0.3127 (12) 0.021 (5)*C6 0.1522 (3) 1.04308 (19) 0.38304 (11) 0.0190 (4)H6B 0.129 (4) 1.121 (3) 0.4193 (13) 0.027 (6)*H6A 0.061 (3) 1.058 (2) 0.3460 (13) 0.019 (5)*C5 0.1299 (3) 0.88357 (18) 0.41643 (9) 0.0160 (3)H5A 0.189 (3) 0.874 (2) 0.4671 (12) 0.019 (5)*H5B −0.004 (3) 0.851 (3) 0.4170 (11) 0.016 (5)*C4 0.2269 (2) 0.64253 (17) 0.34780 (9) 0.0138 (3)C2 0.0842 (2) 0.54949 (18) 0.39562 (10) 0.0146 (3)H2 −0.002 (3) 0.617 (2) 0.4261 (12) 0.019 (5)*C1 −0.0471 (3) 0.4544 (2) 0.34297 (10) 0.0193 (4)H1B −0.102 (4) 0.513 (3) 0.3028 (14) 0.036 (7)*H1A 0.034 (3) 0.373 (3) 0.3187 (12) 0.021 (5)*C3 0.2042 (3) 0.4516 (2) 0.45062 (11) 0.0229 (4)H3A 0.283 (4) 0.512 (3) 0.4836 (14) 0.039 (7)*H3B 0.295 (4) 0.385 (3) 0.4238 (15) 0.044 (7)*H3C 0.122 (3) 0.387 (3) 0.4814 (12) 0.024 (5)*S1 −0.24589 (6) 0.35885 (4) 0.39324 (2) 0.02085 (14)H1S −0.352 (4) 0.475 (3) 0.4021 (15) 0.049 (8)*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O3 0.0132 (5) 0.0260 (6) 0.0290 (6) 0.0009 (7) 0.0030 (5) 0.0119 (5)O2 0.0178 (6) 0.0225 (6) 0.0249 (6) −0.0008 (5) −0.0021 (5) 0.0091 (5)
supporting information
sup-3Acta Cryst. (2015). C71
O1 0.0194 (6) 0.0145 (5) 0.0242 (6) −0.0017 (5) 0.0087 (5) −0.0050 (5)N1 0.0104 (6) 0.0116 (6) 0.0160 (6) −0.0010 (6) 0.0030 (6) −0.0010 (5)C9 0.0147 (7) 0.0125 (7) 0.0201 (8) −0.0022 (6) 0.0001 (6) 0.0011 (6)C8 0.0133 (7) 0.0123 (7) 0.0143 (8) −0.0024 (6) 0.0004 (6) 0.0025 (6)C7 0.0197 (9) 0.0111 (8) 0.0264 (9) −0.0029 (7) 0.0014 (8) 0.0008 (7)C6 0.0236 (9) 0.0108 (8) 0.0226 (9) 0.0015 (7) 0.0017 (8) −0.0011 (7)C5 0.0197 (9) 0.0113 (7) 0.0171 (8) −0.0006 (7) 0.0036 (7) −0.0032 (6)C4 0.0120 (7) 0.0120 (7) 0.0174 (7) 0.0011 (7) 0.0004 (6) 0.0001 (6)C2 0.0151 (7) 0.0109 (7) 0.0178 (8) −0.0020 (6) 0.0036 (6) −0.0010 (7)C1 0.0172 (8) 0.0214 (9) 0.0193 (8) −0.0069 (7) 0.0015 (7) 0.0028 (7)C3 0.0227 (10) 0.0216 (9) 0.0244 (9) −0.0055 (7) −0.0038 (7) 0.0056 (7)S1 0.0171 (2) 0.0193 (2) 0.0261 (2) −0.00726 (19) 0.00309 (19) 0.00129 (15)
Geometric parameters (Å, º)
O3—C9 1.320 (2) C8—C7 1.546 (2)O2—C9 1.211 (2) C7—C6 1.534 (2)O1—C4 1.250 (2) C6—C5 1.528 (2)N1—C4 1.333 (2) C4—C2 1.520 (2)N1—C8 1.467 (2) C2—C3 1.527 (2)N1—C5 1.473 (2) C2—C1 1.531 (2)C9—C8 1.525 (2) C1—S1 1.8187 (17)
C4—N1—C8 119.86 (14) C5—C6—C7 103.30 (14)C4—N1—C5 128.20 (14) N1—C5—C6 102.20 (13)C8—N1—C5 111.91 (12) O1—C4—N1 120.13 (15)O2—C9—O3 120.88 (16) O1—C4—C2 121.20 (14)O2—C9—C8 123.15 (15) N1—C4—C2 118.62 (14)O3—C9—C8 115.94 (14) C4—C2—C3 107.98 (13)N1—C8—C9 110.79 (12) C4—C2—C1 109.64 (13)N1—C8—C7 104.17 (13) C3—C2—C1 112.43 (14)C9—C8—C7 110.96 (14) C2—C1—S1 113.31 (12)C6—C7—C8 104.19 (14)
Hydrogen-bond geometry (Å, º)
D—H···A D—H H···A D···A D—H···A
S1—H1S···O2i 1.26 (3) 2.40 (3) 3.5165 (12) 146.2 (18)O3—H3O···O1ii 0.80 (3) 1.80 (3) 2.5881 (17) 169 (3)C1—H1A···O3iii 1.00 (2) 2.53 (2) 3.300 (2) 133.8 (19)C5—H5A···O2iv 0.98 (2) 2.58 (2) 3.408 (2) 142.4 (15)
Symmetry codes: (i) x−1, y, z; (ii) −x+1, y+1/2, −z+1/2; (iii) −x+1, y−1/2, −z+1/2; (iv) x−1/2, −y+3/2, −z+1.
(2) 1,1′-{Disulfanediylbis[(2S)-2-methyl-1-oxopropane-3,1-diyl]}bis-L-proline
Crystal data
C18H28N2O6S2
Mr = 432.54Monoclinic, P21
a = 6.6678 (4) Å
supporting information
sup-4Acta Cryst. (2015). C71
b = 11.0680 (6) Åc = 14.4219 (8) Åβ = 91.925 (2)°V = 1063.72 (10) Å3
Z = 2F(000) = 460Dx = 1.350 Mg m−3
Cu Kα radiation, λ = 1.54178 ÅCell parameters from 9957 reflectionsθ = 3.1–68.4°µ = 2.59 mm−1
T = 100 KPlate, colourless0.25 × 0.20 × 0.15 mm
Data collection
Bruker SMART APEXII CCD area-detector diffractometer
Radiation source: 30W microsource with MonoCap capillary
Graphite monochromatorω scansAbsorption correction: multi-scan
(SADABS; Sheldrick, 2003)Tmin = 0.622, Tmax = 0.753
11298 measured reflections3675 independent reflections3626 reflections with I > 2σ(I)Rint = 0.019θmax = 68.4°, θmin = 3.1°h = −8→8k = −12→13l = −17→17
Refinement
Refinement on F2
Least-squares matrix: fullR[F2 > 2σ(F2)] = 0.041wR(F2) = 0.105S = 1.043675 reflections255 parameters1 restraintHydrogen site location: inferred from
neighbouring sites
H-atom parameters constrainedw = 1/[σ2(Fo
2) + (0.058P)2 + 0.938P] where P = (Fo
2 + 2Fc2)/3
(Δ/σ)max < 0.001Δρmax = 0.44 e Å−3
Δρmin = −0.25 e Å−3
Absolute structure: Flack x parameter determined using 1578 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Absolute structure parameter: 0.007 (8)
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
S11 0.56018 (13) 0.81825 (9) 0.19681 (7) 0.0276 (2)S1 0.31225 (14) 0.75047 (9) 0.25785 (7) 0.0281 (2)O13 0.9648 (5) 0.3351 (3) 0.0566 (2) 0.0341 (7)H13O 1.0218 0.2810 0.0263 0.041*O3 0.1490 (6) 1.2329 (4) 0.5917 (2) 0.0501 (9)H3O 0.0910 1.2998 0.5971 0.060*O12 1.2691 (6) 0.3606 (5) 0.1177 (4) 0.0816 (17)O11 0.9102 (5) 0.6451 (3) 0.0364 (2) 0.0306 (7)O1 −0.0169 (5) 0.9592 (3) 0.3868 (2) 0.0359 (7)O2 0.1020 (7) 1.2666 (4) 0.4414 (2) 0.0579 (11)N11 0.8104 (5) 0.5242 (3) 0.1497 (2) 0.0259 (7)N1 0.2798 (5) 1.0568 (3) 0.3919 (2) 0.0295 (8)
supporting information
sup-5Acta Cryst. (2015). C71
C19 1.0958 (7) 0.3875 (4) 0.1123 (3) 0.0331 (10)C18 1.0168 (6) 0.4868 (4) 0.1722 (3) 0.0286 (9)H18 1.1071 0.5587 0.1685 0.034*C14 0.7715 (6) 0.6021 (4) 0.0822 (3) 0.0262 (8)C12 0.5552 (6) 0.6370 (4) 0.0603 (3) 0.0272 (9)H12 0.4656 0.5906 0.1016 0.033*C11 0.5259 (6) 0.7719 (4) 0.0765 (3) 0.0272 (9)H11B 0.3888 0.7946 0.0545 0.033*H11A 0.6219 0.8171 0.0387 0.033*C1 0.1135 (6) 0.8507 (4) 0.2149 (3) 0.0271 (9)H1B 0.1044 0.8454 0.1463 0.033*H1A −0.0160 0.8227 0.2388 0.033*C2 0.1456 (6) 0.9819 (4) 0.2427 (3) 0.0253 (8)H2 0.2818 1.0078 0.2235 0.030*C4 0.1335 (6) 0.9968 (4) 0.3465 (3) 0.0266 (9)C8 0.2687 (7) 1.0836 (4) 0.4911 (3) 0.0354 (10)H8 0.1983 1.0177 0.5245 0.042*C9 0.1624 (7) 1.2065 (5) 0.5034 (3) 0.0357 (10)C13 0.5006 (7) 0.6065 (4) −0.0414 (3) 0.0377 (10)H13C 0.5765 0.6590 −0.0822 0.057*H13A 0.3566 0.6193 −0.0531 0.057*H13B 0.5340 0.5219 −0.0536 0.057*C7 0.4899 (9) 1.0893 (5) 0.5204 (4) 0.0509 (14)H7A 0.5105 1.1358 0.5786 0.061*H7B 0.5470 1.0073 0.5291 0.061*C6 0.5819 (8) 1.1533 (6) 0.4393 (4) 0.0529 (15)H6B 0.7274 1.1364 0.4373 0.063*H6A 0.5617 1.2418 0.4434 0.063*C5 0.4698 (7) 1.1012 (5) 0.3540 (4) 0.0422 (12)H5A 0.4442 1.1643 0.3063 0.051*H5B 0.5464 1.0344 0.3263 0.051*C3 −0.0124 (7) 1.0631 (5) 0.1942 (3) 0.0380 (11)H3B −0.1463 1.0405 0.2142 0.057*H3C −0.0061 1.0531 0.1268 0.057*H3A 0.0142 1.1477 0.2105 0.057*C15 0.6687 (7) 0.4762 (4) 0.2187 (3) 0.0365 (10)H15A 0.5564 0.4318 0.1876 0.044*H15B 0.6137 0.5421 0.2566 0.044*C16 0.7998 (8) 0.3918 (4) 0.2776 (3) 0.0391 (11)H16B 0.7971 0.3088 0.2519 0.047*H16A 0.7547 0.3893 0.3423 0.047*C17 1.0086 (8) 0.4461 (5) 0.2734 (3) 0.0405 (11)H17B 1.1134 0.3852 0.2884 0.049*H17A 1.0248 0.5154 0.3164 0.049*
supporting information
sup-6Acta Cryst. (2015). C71
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
S11 0.0237 (4) 0.0279 (5) 0.0311 (5) 0.0034 (4) −0.0017 (3) −0.0063 (4)S1 0.0315 (5) 0.0239 (5) 0.0289 (5) 0.0036 (4) 0.0006 (4) −0.0005 (4)O13 0.0399 (16) 0.0289 (17) 0.0337 (15) 0.0059 (13) 0.0037 (12) −0.0064 (13)O3 0.071 (2) 0.050 (2) 0.0298 (16) 0.0188 (19) 0.0035 (15) −0.0068 (16)O12 0.031 (2) 0.098 (4) 0.115 (4) 0.013 (2) −0.005 (2) −0.069 (3)O11 0.0347 (16) 0.0262 (16) 0.0316 (15) 0.0048 (12) 0.0109 (12) 0.0075 (12)O1 0.0395 (17) 0.0330 (17) 0.0361 (17) −0.0076 (13) 0.0156 (13) −0.0034 (13)O2 0.092 (3) 0.048 (2) 0.0343 (18) 0.022 (2) 0.0062 (18) 0.0041 (17)N11 0.0325 (18) 0.0186 (17) 0.0271 (17) 0.0001 (14) 0.0086 (14) 0.0011 (13)N1 0.0343 (19) 0.030 (2) 0.0245 (17) −0.0018 (15) 0.0067 (14) −0.0038 (14)C19 0.036 (2) 0.029 (3) 0.035 (2) −0.0042 (19) 0.0048 (17) −0.0038 (19)C18 0.029 (2) 0.026 (2) 0.032 (2) 0.0016 (17) 0.0008 (16) 0.0006 (17)C14 0.034 (2) 0.019 (2) 0.0263 (19) 0.0015 (16) 0.0020 (16) −0.0063 (15)C12 0.034 (2) 0.020 (2) 0.0273 (19) −0.0015 (16) 0.0046 (16) −0.0007 (16)C11 0.031 (2) 0.022 (2) 0.0283 (19) 0.0045 (16) 0.0027 (15) −0.0039 (16)C1 0.0226 (18) 0.031 (2) 0.0273 (18) 0.0038 (15) −0.0029 (14) −0.0047 (16)C2 0.0246 (18) 0.025 (2) 0.0259 (19) 0.0033 (16) 0.0026 (14) 0.0006 (17)C4 0.030 (2) 0.021 (2) 0.029 (2) 0.0018 (16) 0.0053 (16) 0.0004 (16)C8 0.049 (3) 0.031 (2) 0.027 (2) 0.000 (2) 0.0010 (19) −0.0031 (18)C9 0.037 (2) 0.046 (3) 0.024 (2) −0.004 (2) 0.0043 (17) −0.005 (2)C13 0.046 (3) 0.031 (3) 0.036 (2) −0.004 (2) −0.0038 (19) −0.0068 (19)C7 0.061 (3) 0.048 (3) 0.044 (3) 0.014 (3) −0.013 (2) −0.015 (2)C6 0.033 (2) 0.068 (4) 0.057 (3) −0.004 (2) 0.000 (2) −0.030 (3)C5 0.032 (2) 0.051 (3) 0.044 (3) −0.010 (2) 0.0118 (19) −0.016 (2)C3 0.040 (2) 0.037 (3) 0.037 (2) 0.013 (2) 0.0033 (19) 0.009 (2)C15 0.043 (3) 0.029 (2) 0.039 (2) 0.004 (2) 0.0141 (19) 0.013 (2)C16 0.055 (3) 0.032 (3) 0.031 (2) 0.009 (2) 0.014 (2) 0.012 (2)C17 0.045 (3) 0.043 (3) 0.033 (2) 0.009 (2) 0.0022 (19) 0.009 (2)
Geometric parameters (Å, º)
S11—C11 1.816 (4) C19—C18 1.504 (6)S11—S1 2.0417 (14) C18—C17 1.529 (6)S1—C1 1.821 (4) C14—C12 1.516 (6)O13—C19 1.303 (5) C12—C11 1.526 (6)O3—C9 1.314 (5) C12—C13 1.536 (6)O12—C19 1.194 (6) C1—C2 1.520 (6)O11—C14 1.248 (5) C2—C4 1.510 (5)O1—C4 1.248 (5) C2—C3 1.536 (6)O2—C9 1.175 (6) C8—C7 1.522 (7)N11—C14 1.320 (5) C8—C9 1.546 (7)N11—C18 1.463 (5) C7—C6 1.515 (9)N11—C15 1.493 (5) C6—C5 1.531 (7)N1—C4 1.334 (6) C15—C16 1.520 (6)N1—C8 1.466 (5) C16—C17 1.519 (7)
supporting information
sup-7Acta Cryst. (2015). C71
N1—C5 1.480 (6)
C11—S11—S1 103.32 (14) C12—C11—S11 114.2 (3)C1—S1—S11 102.70 (15) C2—C1—S1 113.4 (3)C14—N11—C18 120.6 (3) C4—C2—C1 110.8 (3)C14—N11—C15 127.7 (4) C4—C2—C3 109.2 (3)C18—N11—C15 111.3 (3) C1—C2—C3 110.5 (4)C4—N1—C8 121.3 (4) O1—C4—N1 121.6 (4)C4—N1—C5 127.2 (4) O1—C4—C2 119.7 (4)C8—N1—C5 111.4 (4) N1—C4—C2 118.6 (4)O12—C19—O13 123.8 (4) N1—C8—C7 101.5 (4)O12—C19—C18 120.2 (4) N1—C8—C9 109.2 (4)O13—C19—C18 116.1 (4) C7—C8—C9 112.1 (4)N11—C18—C19 115.1 (4) O2—C9—O3 125.4 (5)N11—C18—C17 103.4 (3) O2—C9—C8 123.9 (4)C19—C18—C17 110.9 (4) O3—C9—C8 110.7 (4)O11—C14—N11 120.6 (4) C6—C7—C8 102.6 (4)O11—C14—C12 120.6 (4) C7—C6—C5 104.2 (4)N11—C14—C12 118.8 (4) N1—C5—C6 103.2 (4)C14—C12—C11 110.1 (3) N11—C15—C16 103.1 (4)C14—C12—C13 109.6 (3) C15—C16—C17 104.2 (4)C11—C12—C13 109.5 (3) C16—C17—C18 102.6 (4)
C14—N11—C18—C19 −82.7 (5) C5—N1—C4—C2 −7.2 (7)C15—N11—C18—C19 104.4 (4) C1—C2—C4—O1 −53.8 (5)C14—N11—C18—C17 156.2 (4) C3—C2—C4—O1 68.2 (5)C15—N11—C18—C17 −16.7 (5) C1—C2—C4—N1 130.2 (4)O12—C19—C18—N11 171.0 (5) C3—C2—C4—N1 −107.9 (4)O13—C19—C18—N11 −9.2 (5) C4—N1—C8—C7 152.1 (4)O12—C19—C18—C17 −72.1 (6) C5—N1—C8—C7 −26.4 (5)O13—C19—C18—C17 107.7 (4) C4—N1—C8—C9 −89.5 (5)C18—N11—C14—O11 0.0 (6) C5—N1—C8—C9 92.1 (5)C15—N11—C14—O11 171.5 (4) N1—C8—C9—O2 0.0 (7)C18—N11—C14—C12 179.2 (3) C7—C8—C9—O2 111.6 (6)C15—N11—C14—C12 −9.3 (6) N1—C8—C9—O3 179.7 (4)O11—C14—C12—C11 −63.1 (5) C7—C8—C9—O3 −68.7 (5)N11—C14—C12—C11 117.8 (4) N1—C8—C7—C6 39.5 (5)O11—C14—C12—C13 57.5 (5) C9—C8—C7—C6 −76.8 (5)N11—C14—C12—C13 −121.7 (4) C8—C7—C6—C5 −39.1 (5)C14—C12—C11—S11 −65.4 (4) C4—N1—C5—C6 −175.8 (5)C13—C12—C11—S11 174.0 (3) C8—N1—C5—C6 2.5 (6)S1—S11—C11—C12 −71.7 (3) C7—C6—C5—N1 22.8 (6)S11—S1—C1—C2 −61.0 (3) C14—N11—C15—C16 −179.9 (4)S1—C1—C2—C4 −66.0 (4) C18—N11—C15—C16 −7.7 (5)S1—C1—C2—C3 172.9 (3) N11—C15—C16—C17 29.2 (5)C8—N1—C4—O1 −1.3 (6) C15—C16—C17—C18 −39.6 (5)C5—N1—C4—O1 176.9 (4) N11—C18—C17—C16 34.2 (4)C8—N1—C4—C2 174.6 (4) C19—C18—C17—C16 −89.7 (4)
supporting information
sup-8Acta Cryst. (2015). C71
Hydrogen-bond geometry (Å, º)
D—H···A D—H H···A D···A D—H···A
O1—H1···N1 0.82 2.36 3.162 (3) 165O3—H3O···O1i 0.84 1.85 2.677 (5) 168O13—H13O···O11ii 0.84 1.82 2.644 (5) 167C1—H1A···S11iii 0.99 2.87 3.707 (4) 143C2—H2···S11 1.00 2.84 3.389 (4) 115C11—H11A···O12iv 0.99 2.44 3.307 (7) 146C13—H13C···O12iv 0.98 2.52 3.405 (7) 151C15—H15A···O12iii 0.99 2.28 3.255 (7) 170C17—H17B···O2v 0.99 2.57 3.179 (6) 120C18—H18···S1vi 1.00 2.81 3.709 (4) 149
Symmetry codes: (i) −x, y+1/2, −z+1; (ii) −x+2, y−1/2, −z; (iii) x−1, y, z; (iv) −x+2, y+1/2, −z; (v) x+1, y−1, z; (vi) x+1, y, z.
Experimental (X-ray) and theoretical (Monte Carlo) torsion angles for (1)
Supplementary materials
Exp. (1) Theor. (1)S1–C1–C2–C3 67.9 70.0S1–C1–C2–C4 -171.9 -168.9C1–C2–C4–O1 -52.2 -55.2C1–C2–C4–N1 130.5 125.9C3–C2–C4–O1 70.6 68.5C3–C2–C4–N1 -106.7 -110.4O1–C4–N1–C5 178.0 -177.7O1–C4–N1–C8 -4.1 3.4C2–C4–N1–C5 -4.7 1.1C2–C4–N1–C8 173.2 -177.7C6–C5–N1–C4 -156.6 176.8C6–C5–N1–C8 25.3 -4.2N1–C5–C6–C7 -36.5 22.5C5–C6–C7–C8 35.2 -31.8C6–C7–C8–N1 -19.8 29.3C6–C7–C8–C9 -139.1 -92.9C7–C8–N1–C4 178.3 163.4C7–C8–N1–C5 -3.5 -15.6C9–C8–N1–C4 -62.4 -73.0C9–C8–N1–C5 115.8 107.9N1–C8–C9–O2 -19.9 -116.8N1–C8–C9–O3 162.0 63.4C7–C8–C9–O2 95.3 1.0C7–C8–C9–O3 -82.8 -178.7
supporting information
sup-9Acta Cryst. (2015). C71
Experimental (X-ray) and theoretical (Monte Carlo) torsion angles for (2)
Supplementary materials
Exp. (2) Theor. (2)S1–C1–C2–C3 172.9 72.5S1–C1–C2–C4 -66.0 -163.3C1–C2–C4–O1 -53.8 -89.2C1–C2–C4–N1 130.2 91.5C3–C2–C4–O1 68.1 35.3C3–C2–C4–N1 -107.9 -144.0O1–C4–N1–C5 176.9 -179.1O1–C4–N1–C8 -1.3 3.8C2–C4–N1–C5 -7.2 0.3C2–C4–N1–C8 174.6 -176.9C6–C5–N1–C4 -175.8 178.4C6–C5–N1–C8 2.5 -4.1N1–C5–C6–C7 22.8 22.1C5–C6–C7–C8 -39.0 -31.2C6–C7–C8–N1 39.5 28.7C6–C7–C8–C9 -76.9 -93.2C7–C8–N1–C4 152.1 162.2C7–C8–N1–C5 -26.4 -15.3C9–C8–N1–C4 -89.5 -74.2C9–C8–N1–C5 92.1 108.2N1–C8–C9–O2 0.0 -116.5N1–C8–C9–O3 179.7 63.7C7–C8–C9–O2 111.6 1.3C7–C8–C9–O3 -68.8 -178.5C1–S1–S11–C11 -73.5 81.6S11–S1–C1–C2 -61.0 66.7S1–S11–C11–C12 -71.7 -178.0S11–C11–C12–C13 174.0 69.9S11–C11–C12–C14 -65.4 -167.7C11–C12–C14–O11 -63.1 -49.9C11–C12–C14–N11 117.8 130.3C13–C12–C14–O11 57.4 73.8C13–C12–C14–N11 -121.6 -106.0O11–C14–N11–C15 171.5 179.4O11–C14–N11–C18 0.1 0.3C12–C14–N11–C15 -9.4 -0.9C12–C14–N11–C18 179.1 -179.9C16–C15–N11-C14 -179.8 176.7C16–C15–N11–C18 -7.7 -4.2N11–C15–C16–C17 29.2 20.9C15–C16–C17–C18 -39.6 -29.3C16–C17–C18–N11 34.2 26.9C16–C17–C18–C19 -89.7 -94.3C17–C18–N11–C14 156.1 165.0